Protection against ischemic stroke damage by synergistic treatment with amlodipine plus atorvastatin in Zucker metabolic rat

Hiromi Kawai, Shoko Deguchi, Kentaro Deguchi, Toru Yamashita, Yasuyuki Ohta, Yoshio Omote, Tomoko Kurata, Yoshio Ikeda, Tohru Matsuura, Koji Abe

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Ischemic stroke is a major neurologic disorder and a leading cause of disability and death in the world. We compared neuroprotective effects of single or combination therapy of amlodipine (AM) and atorvastatin (AT) in such a metabolic syndrome model Zucker rat. The animals were pretreated with vehicle, AM, AT, or the combination of AM plus AT for 28 days, and physical and serum parameters were analyzed, then 90 min of transient middle cerebral artery occlusion (tMCAO), was performed followed by immunohistochemical analyses at 24 h. Without affecting serum levels of lipids, adiponectin, and leptin, the combination therapy of AM plus AT ameliorated the post-ischemic brain weight increase. The single treatment with AM or AT itself exerted neuroprotective effects with reducing inductions of MMP-9 and AT2R, as well as with preserving collagen IV, and the combination therapy of AM plus AT showed a further synergistic benefit against acute ischemic neural damages. Single AT was more protective on these 3 molecules than single AM at this time point of 24 h after tMCAO. Thus, the combination therapy with AM plus AT extended the neuroprotectives effect of single treatment with AM or AT on a part of neurovascular unit and a hypertension-related receptor.

Original languageEnglish
Pages (from-to)308-314
Number of pages7
JournalBrain Research
Volume1382
DOIs
Publication statusPublished - Mar 25 2011

Fingerprint

Zucker Rats
Stroke
Neuroprotective Agents
Middle Cerebral Artery Infarction
Therapeutics
Amlodipine
atorvastatin drug combination amlodipine
Adiponectin
Leptin
Nervous System Diseases
Serum
Matrix Metalloproteinases
Cause of Death
Collagen
Hypertension
Lipids
Weights and Measures
Brain

Keywords

  • Amlodipine
  • AT2R
  • Atorvastatin
  • Cerebral infarction
  • Collagen IV
  • MMP-9
  • Zucker rat

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology
  • Developmental Biology
  • Molecular Biology

Cite this

Protection against ischemic stroke damage by synergistic treatment with amlodipine plus atorvastatin in Zucker metabolic rat. / Kawai, Hiromi; Deguchi, Shoko; Deguchi, Kentaro; Yamashita, Toru; Ohta, Yasuyuki; Omote, Yoshio; Kurata, Tomoko; Ikeda, Yoshio; Matsuura, Tohru; Abe, Koji.

In: Brain Research, Vol. 1382, 25.03.2011, p. 308-314.

Research output: Contribution to journalArticle

Kawai, Hiromi ; Deguchi, Shoko ; Deguchi, Kentaro ; Yamashita, Toru ; Ohta, Yasuyuki ; Omote, Yoshio ; Kurata, Tomoko ; Ikeda, Yoshio ; Matsuura, Tohru ; Abe, Koji. / Protection against ischemic stroke damage by synergistic treatment with amlodipine plus atorvastatin in Zucker metabolic rat. In: Brain Research. 2011 ; Vol. 1382. pp. 308-314.
@article{cf828e20f15041e3935e70df846f3b4b,
title = "Protection against ischemic stroke damage by synergistic treatment with amlodipine plus atorvastatin in Zucker metabolic rat",
abstract = "Ischemic stroke is a major neurologic disorder and a leading cause of disability and death in the world. We compared neuroprotective effects of single or combination therapy of amlodipine (AM) and atorvastatin (AT) in such a metabolic syndrome model Zucker rat. The animals were pretreated with vehicle, AM, AT, or the combination of AM plus AT for 28 days, and physical and serum parameters were analyzed, then 90 min of transient middle cerebral artery occlusion (tMCAO), was performed followed by immunohistochemical analyses at 24 h. Without affecting serum levels of lipids, adiponectin, and leptin, the combination therapy of AM plus AT ameliorated the post-ischemic brain weight increase. The single treatment with AM or AT itself exerted neuroprotective effects with reducing inductions of MMP-9 and AT2R, as well as with preserving collagen IV, and the combination therapy of AM plus AT showed a further synergistic benefit against acute ischemic neural damages. Single AT was more protective on these 3 molecules than single AM at this time point of 24 h after tMCAO. Thus, the combination therapy with AM plus AT extended the neuroprotectives effect of single treatment with AM or AT on a part of neurovascular unit and a hypertension-related receptor.",
keywords = "Amlodipine, AT2R, Atorvastatin, Cerebral infarction, Collagen IV, MMP-9, Zucker rat",
author = "Hiromi Kawai and Shoko Deguchi and Kentaro Deguchi and Toru Yamashita and Yasuyuki Ohta and Yoshio Omote and Tomoko Kurata and Yoshio Ikeda and Tohru Matsuura and Koji Abe",
year = "2011",
month = "3",
day = "25",
doi = "10.1016/j.brainres.2011.01.062",
language = "English",
volume = "1382",
pages = "308--314",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",

}

TY - JOUR

T1 - Protection against ischemic stroke damage by synergistic treatment with amlodipine plus atorvastatin in Zucker metabolic rat

AU - Kawai, Hiromi

AU - Deguchi, Shoko

AU - Deguchi, Kentaro

AU - Yamashita, Toru

AU - Ohta, Yasuyuki

AU - Omote, Yoshio

AU - Kurata, Tomoko

AU - Ikeda, Yoshio

AU - Matsuura, Tohru

AU - Abe, Koji

PY - 2011/3/25

Y1 - 2011/3/25

N2 - Ischemic stroke is a major neurologic disorder and a leading cause of disability and death in the world. We compared neuroprotective effects of single or combination therapy of amlodipine (AM) and atorvastatin (AT) in such a metabolic syndrome model Zucker rat. The animals were pretreated with vehicle, AM, AT, or the combination of AM plus AT for 28 days, and physical and serum parameters were analyzed, then 90 min of transient middle cerebral artery occlusion (tMCAO), was performed followed by immunohistochemical analyses at 24 h. Without affecting serum levels of lipids, adiponectin, and leptin, the combination therapy of AM plus AT ameliorated the post-ischemic brain weight increase. The single treatment with AM or AT itself exerted neuroprotective effects with reducing inductions of MMP-9 and AT2R, as well as with preserving collagen IV, and the combination therapy of AM plus AT showed a further synergistic benefit against acute ischemic neural damages. Single AT was more protective on these 3 molecules than single AM at this time point of 24 h after tMCAO. Thus, the combination therapy with AM plus AT extended the neuroprotectives effect of single treatment with AM or AT on a part of neurovascular unit and a hypertension-related receptor.

AB - Ischemic stroke is a major neurologic disorder and a leading cause of disability and death in the world. We compared neuroprotective effects of single or combination therapy of amlodipine (AM) and atorvastatin (AT) in such a metabolic syndrome model Zucker rat. The animals were pretreated with vehicle, AM, AT, or the combination of AM plus AT for 28 days, and physical and serum parameters were analyzed, then 90 min of transient middle cerebral artery occlusion (tMCAO), was performed followed by immunohistochemical analyses at 24 h. Without affecting serum levels of lipids, adiponectin, and leptin, the combination therapy of AM plus AT ameliorated the post-ischemic brain weight increase. The single treatment with AM or AT itself exerted neuroprotective effects with reducing inductions of MMP-9 and AT2R, as well as with preserving collagen IV, and the combination therapy of AM plus AT showed a further synergistic benefit against acute ischemic neural damages. Single AT was more protective on these 3 molecules than single AM at this time point of 24 h after tMCAO. Thus, the combination therapy with AM plus AT extended the neuroprotectives effect of single treatment with AM or AT on a part of neurovascular unit and a hypertension-related receptor.

KW - Amlodipine

KW - AT2R

KW - Atorvastatin

KW - Cerebral infarction

KW - Collagen IV

KW - MMP-9

KW - Zucker rat

UR - http://www.scopus.com/inward/record.url?scp=79952535409&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952535409&partnerID=8YFLogxK

U2 - 10.1016/j.brainres.2011.01.062

DO - 10.1016/j.brainres.2011.01.062

M3 - Article

C2 - 21276424

AN - SCOPUS:79952535409

VL - 1382

SP - 308

EP - 314

JO - Brain Research

JF - Brain Research

SN - 0006-8993

ER -